Is SIRT2 required for necroptosis?
Kim Newton(Gene Therapy Laboratory), John Silke(Walter and Eliza Hall Institute of Medical Research)
Cited by 27
Related Papers
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
|Cell Death and Differentiation|2016|439
TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1–TRAF2 complex to sensitize tumor cells to TNFα
|The Journal of Cell Biology|2008|236
TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-κB and to Prevent TNF-induced Apoptosis
|Journal of Biological Chemistry|2009|231
Direct inhibition of caspase 3 is dispensable for the anti‐apoptotic activity of XIAP
|The EMBO Journal|2001|117